Related Experiment Video
Updated: Jan 17, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
Functional interaction between immune checkpoints and lipid metabolism in the development of arteriosclerosis
Junyi Zhang1, Liyuan Cui2,3,4, Xinhang Meng2,3,4
1Department of Interventional Vascular Surgery, Xinhua Hospital, Shanghai JiaoTong University, School of Medicine, Shanghai, China.
Insights
Arteriosclerosis obliterans (ASO) involves complex lipid metabolism and inflammation. Immune checkpoints regulate lipid metabolism, influencing ASO progression and offering potential therapeutic targets.
Area of Science:
- Vascular Biology
- Immunology
- Metabolic Disorders
Background:
- Arteriosclerosis obliterans (ASO) is a chronic vascular disease causing limb loss.
- ASO pathogenesis involves lipid metabolism disorders and chronic inflammation.
- Immune checkpoints are key regulators of the immune microenvironment in ASO.
Purpose of the Study:
- To review the role of immune checkpoints in ASO.
- To discuss how immune checkpoints influence lipid metabolism in ASO.
- To identify potential therapeutic targets by exploring interactions between lipid metabolism and immune checkpoints.
Main Methods:
- Literature review and synthesis of current research.
- Analysis of the interplay between immune checkpoints and lipid metabolism pathways.
- Discussion of the implications for ASO pathogenesis and treatment.
Main Results:
- Immune checkpoints significantly impact the immune microenvironment in ASO.
- Immune checkpoints modulate immune cell metabolism, affecting lipid absorption, transport, and degradation.
- This regulation of lipid metabolism by immune checkpoints plays a crucial role in ASO development and progression.
Conclusions:
- Immune checkpoints are critical regulators in ASO, influencing lipid metabolism.
- Understanding the interaction between lipid metabolism and immune checkpoints is vital for ASO management.
- Further research may reveal novel therapeutic strategies targeting these pathways for ASO.
Abstract:
Arteriosclerosis obliterans (ASO) is a chronic vascular disease characterized by narrowing or occlusion of the vascular lumen. Its pathogenesis is complex and closely associated with lipid metabolism disorders and chronic inflammation. Although notable progress has been made in the treatment of ASO, it still remains a cause of surgical limb loss globally. In recent years, immune checkpoints have been identified as critical regulators of the immune microenvironment that play a significant role in ASO. Furthermore, immune checkpoints can affect lipid metabolism by regulating the metabolic pathways of immune cells, thereby indirectly modulating lipid metabolic processes, such as lipid absorption, transport, and degradation, which are crucial in the development and progression of atherosclerosis. Here, we summarized and discussed progress in studies related to lipid metabolism and immune checkpoints during ASO, and highlighted how immune checkpoints regulate lipid metabolism to affect ASO. Further exploration of the interactions between lipid metabolism regulators and immune checkpoints may uncover novel potential therapeutic targets for ASO management.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
